Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued (2017 - 2018)

Historic Preferred Shares Issued for Crinetics Pharmaceuticals (CRNX) over the last 2 years, with Q4 2018 value amounting to $9000.0.

  • Crinetics Pharmaceuticals' Preferred Shares Issued fell 9987.58% to $9000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $63.3 million, marking a year-over-year change of. This contributed to the annual value of $63.3 million for FY2018, which is 42865.74% up from last year.
  • Per Crinetics Pharmaceuticals' latest filing, its Preferred Shares Issued stood at $9000.0 for Q4 2018, which was down 9987.58% from -$127000.0 recorded in Q2 2018.
  • In the past 5 years, Crinetics Pharmaceuticals' Preferred Shares Issued registered a high of $63.4 million during Q1 2018, and its lowest value of -$127000.0 during Q2 2018.